https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Kidneys-MC.jpg

Prostate Cancer Treatment Devices Market Analysis | United States | 2016-2022 | MedCore

  • Year: 2016
  • Scope: 2012-2022
  • Region: United States
  • Pages: 81
  • Published Date: 7/1/2016
  • Type: MedCore

Unlike other cancer treatments, brachytherapy has a history that spans over a century. In 1901, Pierre Curie, a physicist from France, first suggested that radiation could be used to treat cancer to one of his colleagues, a doctor named Henri-Alexandre Danlos. Dr. Danlos tested the idea and found that radiation caused tumors to shrink. Early techniques of brachytherapy were first performed at the Curie institute by Dr. Danlos. Over the next fifty years, doctors around the globe (through trial and error) expanded clinical applications of brachytherapy to include cervical, prostate and breast. Towards the end of the 20th century, brachytherapy received a huge stimulation from imaging technologies such as magnetic resonance imaging (MRI), computer tomography (CT) and ultrasound. This allowed doctors to place the radioactive materials in precise locations in the body. RTi may be broken down into permanent and temporary modalities. Cryoablation is the use of freezing temperatures to erode and destroy specific tissue cells. What is known as modern cryoablation therapy began in the early 1960s when cryosurgical probes cooled by liquid nitrogen were introduced. In the 1970s, handheld cryoablation devices were developed for cardiac purposes. As time went on, cryoablation has evolved into an exact science. Modern cryoablation can be described in four stages: freeze, thaw, hemorrhage and inflammation and replacement fibrosis. The theory claims that, during the initial phase, the cellular metabolism of the tissue is slowed and the area experiences progressive hypothermia. Once the thaw begins, the tissue experiences cellular damage, which culminates in vascular obliteration and ischemic cellular necrosis. Cryoablation uses compressed argon gas as a coolant. As the gas progresses through the needle, the end of the needle develops an ice ball that is then used to “ablate” the desired tissue. The market for cryoablation is a little bit different from other ablations. Of all procedures performed in 2015, half of them originated from capital units that were already installed and the other half came from rentals. As such, the cryoablation models in this chapter are split into rentals (which include disposables), disposables used by an existing installed base and the machines themselves. When a hospital needs to perform a cryo procedure that does not own the capital equipment, they can have it dropped off (complete with the disposables) for a fee. For hospitals that do not have the funds or lack a sufficient customer base, this arrangement can be desirable.



The "US Market Report Suite for Urological Devices 2016 - MedSuite" includes analysis on the following companies currently active in this market:
AmeCath
Aspide
Astora
Best Medical
Biolitec
Boston Scientific
C.R. Bard
Calcula Technologies
Caldera
Cogentix
Coloplast
Convergent Lasers
Cook Medical
Cooper Surgical
Cousin Biotech
Dornier
DynaMesh
Eckert and Ziegler
EDAP
Electro Medical Technologies
Elekta
Ethicon
Galil Medical
GE Oncura
Healthtronics
Hollister
IsoAid
IsoRay
Karl Storz
Laborie
Lumenis
Medifocus
MediPlus
Medline
MedTech
Medtronic
Olympus
Prometheus
Prostalund
Quanta Systems
Richard Worlf
Siemens
SRS Medical
Teleflex
Theragenics
Trimedyne
Urologix
Urotech
Varian
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology